Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?

The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...

Chrissy had a medical reason. The post Chrissy Teigen’s Tragic Reason for Using Weight-Loss Drug appeared first on Reality Tea.

Next generation weight loss drugs are prohibitively expensive for many in the US who would benefit from taking them—and may remain so, thanks to the phenomenon of patent thickets. Paige Huffman ...

Increasingly, Ozempic is being bought without a doctor’s prescription by people who simply want to lose weight.

In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 ...

Novo Nordisk said an older version of its weight-loss drug semaglutide failed to meet its main goal in late-stage trials ...

In the first quarter of 2018, there were less than five postpartum GLP-1 prescriptions, but by the second quarter of 2022, the number rose to 34 per 10,000 and sharply increased to 173 per 10,000 in ...

Novo Nordisk’s stock is experiencing a steep drop following major clinical setbacks and intensifying competitive pressure in ...

In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 ...

As the body positivity era gives way to a “thin is in” moment, telehealth platforms are seizing the opportunity to cash in. Increasingly, their marketing is positioning blockbuster weight-loss shots ...

In an era where the conversation around weight loss is often dominated by the latest injectable medications, many might wonder if the more established tools, like bariatric surgery, still hold a place ...